From Wikipedia, the free encyclopedia
Chemical compound
AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of
major depressive disorder.
[1]
[2]
[3] It was also under development for
anxiety disorders, but development for this indication was discontinued.
[1] The drug acts as a
serotonin–dopamine reuptake inhibitor (SDRI).
[1]
[2]
[3] As of November of 2018, it is in an agreement for
phase II
clinical trials for major depressive disorder.
[4]
See also
References
|
---|
DATTooltip Dopamine transporter (
DRIsTooltip Dopamine reuptake inhibitors) | |
---|
NETTooltip Norepinephrine transporter (
NRIsTooltip Norepinephrine reuptake inhibitors) | | | | | | |
- Others:
Antihistamines (e.g.,
brompheniramine,
chlorphenamine,
pheniramine,
tripelennamine)
-
Antipsychotics (e.g.,
loxapine,
ziprasidone)
-
Arylcyclohexylamines (e.g.,
ketamine,
phencyclidine)
-
Dopexamine
-
Ephenidine
-
Ginkgo biloba
-
Indeloxazine
-
Nefazodone
-
Opioids (e.g.,
desmetramadol,
methadone,
pethidine (meperidine),
tapentadol,
tramadol,
levorphanol)
|
|
---|
SERTTooltip Serotonin transporter (
SRIsTooltip Serotonin reuptake inhibitors) | | | | |
- Others:
A-80426
-
Amoxapine
-
Antihistamines (e.g.,
brompheniramine,
chlorphenamine,
dimenhydrinate,
diphenhydramine,
mepyramine (pyrilamine),
pheniramine,
tripelennamine)
-
Antipsychotics (e.g.,
loxapine,
ziprasidone)
-
Arylcyclohexylamines (e.g.,
3-MeO-PCP,
esketamine,
ketamine,
methoxetamine,
phencyclidine)
-
Cyclobenzaprine
-
Delucemine
-
Dextromethorphan
-
Dextrorphan
-
Efavirenz
-
Hypidone
-
Medifoxamine
-
Mesembrine
-
Mifepristone
-
MIN-117 (WF-516)
-
N-Me-5-HT
-
Opioids (e.g.,
dextropropoxyphene,
methadone,
pethidine (meperidine),
levorphanol,
tapentadol,
tramadol)
-
Roxindole
|
|
---|
VMATsTooltip Vesicular monoamine transporters | |
---|
Others | |
---|
|